Note: Ingredients listed on restricted chemical lists
EC/CAS
204-102-8/115-71-9
Name of the chemical
5-(2,3-Dimethyl-tricyclo[2.2.1.02,6]-hept-3-yl)-2-methylpent-2-en-1-ol (alpha-Santalol); (1S-(1a,2a(Z),4a))-2-Methyl-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)-2-penten-1-ol (beta-Santalol) (40)
Concentration
[ 10-20 ]
EC/CAS
225-004-1/4602-84-0
Name of the chemical
2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl
Concentration
[ 0-1 ]
General Information
Revision date
2023-05-11
Product name
SANTAL SPICATUM AUSTRALIE ESS
CAS No.
8024-35-9
1.2.2. Uses advised against
Industrial use only End use Fragrances / Cosmetic
Emergency telephone
+33(6) 07 85 74 60, +33(8) 20 20 18 16, +33(1) 45 42 59 59
Icons in SDS
Company Information
company name
PCW
e-mail address of the competent person responsible for the Safety Data Sheet
info@pcwfrance.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H411
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
RegulationCLP) Aquatic Chronic 2 Hazardous to the aquatic environment, long-trem hazard 2 Skin. Sens. 1 Sensitisation skin 1 H317 - May cause an allergic skin reaction. H411 - Toxic to aquatic life with long lasting effects. (RegulationCLP) Warning mention : Warning Aquatic Chronic 2 Hazardous to the aquatic environment, long-trem hazard 2 Skin. Sens. 1 Sensitisation skin 1 H317 - May cause an allergic skin reaction. H411 - Toxic to aquatic life with long lasting effects. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P363 - Wash contaminated clothing before reuse. P501 - Dispose of contents/container according to the local/ regional / national / international Regulation.
2.3 Other hazards
The substance/mixture does not contain components considered to have endocrine disrupting properties according to Article 57(f) of REACH or Commission Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0,1 % or more.
Contains
5-(2,3-Dimethyltricyclo[2.2.1.02,6]h ept-3-yl)-2-methylpent-2-en-1-ol, stereoisomer, (E)- alpha-bisabolene CMR (Reg. 1223/2009/EEC) : See certificate
